CRISPR-Cas9 Mediated UGA1 Knockout in Saccharomyces cerevisiae for Enhanced GABA Production in Wort Beverage
Processes · 23.04.2026 · 14 (9) · 1347
DOI: 10.3390/pr14091347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Processes, online erschienen am 23.04.2026. Verfasst von Zhuoling Ding und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
γ-Aminobutyric acid (GABA), a major inhibitory neurotransmitter, is known for its physiological functions in alleviating anxiety and improving sleep. Currently, high-yielding GABA food products are mainly obtained through screening wild-type high-producing strains (e.g., Saccharomyces cerevisiae isolated from Sichuan pickles yielding 0.67 g/L) or employing co-culture systems (e.g., Enterococcus faecium and Lactiplantibacillus plantarum reaching 6.35 g/L). While effective, these methods often rely on natural screening strains or multi-microbial interactions. This study employed CRISPR-Cas9 technology to knockout the UGA1 gene in Saccharomyces cerevisiae, a key gene responsible for GABA degradation. Starting from the low higher alcohol Saccharomyces cerevisiae SY-LH, we successfully constructed the recombinant strain SY-LHU. Remarkably, this study discovered a significant upregulation of GAD1 gene expression following UGA1 knockout, which further enhanced GABA synthesis capacity. Under optimal fermentation conditions (inoculum size 4 × 107 cells/mL, wort concentration 10 °P, sugar addition 60 g/L, 30 °C for 10 days, and mixing the malt broth every 48 h), the validation fermentation was performed and the GABA content in the wort beverage reached 280.36 mg/L, representing a 385.4% increase compared to the pre-optimization level. Furthermore, sensory evaluation by a trained panel yielded a mean score of 88, with no significant off-flavors detected, demonstrating the product’s high consumer acceptance. This pioneering work provides a novel and feasible technical pathway for developing functional alcoholic beverages with sleep-aiding properties.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ding, Z., Tuerxun, K., Luo, X., & Zhou, S. (2026). CRISPR-Cas9 Mediated UGA1 Knockout in Saccharomyces cerevisiae for Enhanced GABA Production in Wort Beverage. Processes, 14(9), 1347. https://doi.org/10.3390/pr14091347
Vancouver
Ding Z, Tuerxun K, Luo X, Zhou S. CRISPR-Cas9 Mediated UGA1 Knockout in Saccharomyces cerevisiae for Enhanced GABA Production in Wort Beverage. Processes. 2026;14(9):1347. doi:10.3390/pr14091347
BibTeX
@article{Ding2026,
author = {Ding, Zhuoling and Tuerxun, Kadireya and Luo, Xueqing and Zhou, Shishui},
title = {CRISPR-Cas9 Mediated UGA1 Knockout in Saccharomyces cerevisiae for Enhanced GABA Production in Wort Beverage},
journal = {Processes},
year = {2026},
volume = {14},
number = {9},
pages = {1347},
doi = {10.3390/pr14091347}
}
EUVIMED